Table 2.
ASE‡ | # | CEPH (n = 45) | NFPTR (n = 100) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEPH | NFPTR | SNPs | #Genotypes | #hets | #ASE | %ASE | θ | FC‡ | #Genotypes | #hets | #ASE | %ASE | θ | FC‡ |
+ | + | 211 | 7,970 | 3,162 | 1,043 | 33 | 1.57 | 3.0 | 17,442 | 6,706 | 2,004 | 30 | 1.50 | 2.8 |
+ | − | 14 | 469 | 176 | 19 | 11 | 1.47 | 2.8 | 938 | 350 | 0 | 0 | 0.37 | 1.3 |
− | + | 81 | 2,513 | 855 | 0 | 0 | 0.37 | 1.3 | 6,199 | 2,261 | 306 | 14 | 1.36 | 2.6 |
− | − | 86 | 3,127 | 1,170 | 0 | 0 | 0.30 | 1.2 | 7,025 | 2,557 | 0 | 0 | 0.32 | 1.2 |
The +/− categories refer to heterozygotes showing and not showing ASE, respectively.
FC indicates fold change calculated from θ.